49 Introduction 50
Type 3 secretion systems (T3SSs) are present in and are essential for the 9 146
It was plausible that copper could have a non-specific effect on the formation of 147 translocon pores. We therefore tested the impact of copper on the efficiency of translocon 148 pore formation in the plasma membranes of erythrocytes. In this assay, formation of a 149 translocon pore causes erythrocyte lysis and hemoglobin release, such that hemoglobin 150 abundance in the media is a measure of the efficiency of translocon pore formation [5, 6,
151 18]. Hemoglobin released from erythrocytes co-cultured with strains of S. flexneri 152 producing WT IpaC, IpaC A38C, or IpaC A353C was unchanged by the presence of 153 copper ( Fig S1a-b ). Copper did not cause erythrocyte lysis on its own, nor did it change 154 the dependence of hemoglobin release on IpaC (Fig S1a-b) . These data demonstrate 155 that neither the formation of intermolecular bonds between IpaC molecules nor the 156 presence of copper per se interferes with pore formation.
168 Intermolecular crosslinking of IpaC inhibits intermediate filament-dependent
169 docking of the type 3 secretion system onto the translocon pore 170 We hypothesized that if interactions of the translocon pore with intermediate 171 filaments alter the pore conformation in a manner that enables docking, crosslinking the 172 pore might restrict movement of the pore proteins, thereby trapping it in a docking-173 incompetent state, leading to fewer bacteria stably associated with cells. To test this, we 174 examined bacterial docking in Vim +/+ and Vim -/cells infected with S. flexneri expressing 12 213 translocon pore proteins to the extracellular surface. To test this hypothesis, we compared 214 the extracellular accessibility of single cysteine substitutions in IpaC in the presence and 215 absence of interaction of IpaC with intermediate filaments. IpaC cysteine substitutions 216 were labeled by methoxypolyethylene glycol maleimide (PEG5000-maleimde), a probe 217 that reacts specifically with sulfhydryl groups present in cysteines, as described [16] .
218 Because PEG5000-maleimide is unable to cross the plasma membrane [19] and is too 219 large to pass entirely through the translocon pore [5, 6] , this approach specifically labels 220 cysteine residues accessible from the extracellular surface of the eukaryotic cell (Fig 3a) .
221
The extracellular accessibility of individual cysteine substitutions in IpaC was 222 compared to those in a derivative of IpaC that contains a point mutation (IpaC R362W, 
239
S. flexneri strains producing IpaC R362W cysteine substitutions induced 240 hemoglobin release from erythrocytes as efficiently as WT IpaC ( Fig S2c-d) , which 241 indicates that the cysteine substitutions do not alter the efficiency of translocon pore 242 formation, consistent with single cysteine substitutions in the context of WT IpaC not 243 altering pore formation ( Fig S1a- 245 delivered to the membrane of cells was not altered by the R362W mutation ( Fig S2e) .
246 Thus, IpaC R362W is delivered to the membrane in the same overall orientation in the 247 membrane as WT IpaC and forms translocon pores with similar efficiency to WT IpaC.
248
Although the orientation of IpaC R362W in the plasma membrane is similar to that 255 was significantly reduced for IpaC R362W compared to WT IpaC (Fig 3c-d ). In addition, 256 labeling of the N-terminal residue S17C was slightly but significantly reduced for IpaC 257 R362W compared to WT IpaC, whereas labeling of the cytosolic residue S271C was 258 absent for both IpaC R362W and WT IpaC (Fig 3c-d) . These findings indicate that the 14 259 position in the pore of IpaC residues A106 and S17 is substantially different between the 260 WT IpaC backbone and the IpaC R362W backbone.
261
We also examined residues in the C-terminal domain that appeared to be 262 differentially accessible in the presence and absence of an interaction between IpaC and 263 intermediate filaments. We found that extracellular accessibility of S349C and A353C by 264 PEG5000-maleimide was less efficient in docking-incompetent than in docking-265 competent pores (Fig 3e-f ). In contrast, A358C was similarly accessible in these two 266 contexts (Fig 3e-f ). Again, there was a small but statistically significant reduction in the 267 extracellular accessibility of S17C in IpaC R362W compared to S17C in WT IpaC, but no 268 difference in the accessibility of S271C (Fig 3e-f ). Since the difference we observed in 269 docking-competent pores was increased accessibility for certain cysteines, this difference 270 is not due to steric hindrance from docked bacteria. Together, these data show that the 271 accessibility of some C-terminal IpaC residues is enhanced by the interaction of IpaC with 272 intermediate filaments.
273
Since in pores that could not interact with intermediate filaments, A106C was 274 inaccessible from the extracellular milieu, we tested whether the extracellular accessibility 275 of A106C was also decreased in cells that lack intermediate filaments. We found that 276 IpaC A106C was significantly less accessible in the absence than in the presence of 277 vimentin (Vim -/versus Vim +/+ ) (Fig 3g- 286 change in the translocon pore (Fig 3i) .
287 Docking occurs within 10 minutes of contact with host cells
288
Since we found that intermolecular crosslinking of at the time of initial bacterial 289 contact with cells locked the translocon pore in a docking-incompetent state (Fig 2) . We 295 10 minutes after initial bacterial contact had no effect on docking; in the presence of 296 copper, docking was similar for the strain producing IpaC A38C and the strain producing 297 WT IpaC (Fig 4a-b ). Whereas docking was not affected, the addition of copper at 10
298 minutes post-initiation of infection led to formation of intermolecular crosslinks in IpaC 299 A38C that reduced T3SS secretion as compared to IpaC WT (Fig 4d-e ). This suggests 300 that, independent of docking, additional conformational changes in the pore may be Fig S3) . IpaC 321 residues S17 in the N-terminal extracellular domain, A106 in the transmembrane alpha 322 helix, and S349 and A353 near the C-terminus display significant differences in 323 extracellular accessibility between the docking-competent and the docking-incompetent 324 states of the translocon pore (Fig 3) . The dramatic change in accessibility of A106 325 suggests that the transmembrane alpha helix (residues 100-120) undergoes a rotation 326 such that upon IpaC interaction with intermediate filaments, A106 turns out of the lipid 327 bilayer into the pore channel or is relieved from steric hindrance by other sequences in 328 IpaC or by the second pore protein IpaB. We envision that the rotation of the 329 transmembrane alpha helix is induced by IpaC C-terminal binding to intermediate 330 filaments and is accompanied by movement of residues near the C-terminus into the pore 18 331 channel and shifting of the N-terminal domain, potentially in a manner that opens the 332 extracellular side of the pore (Fig S3) . We postulate that these conformational changes 333 alter the pore so as to accommodate the T3SS needle, thereby leading to efficient 334 docking. Our data are consistent with the previous observation in P. aeruginosa of the 335 T3SS needle tip complex contacting residues in the C-terminal domain of PopD [9], the 336 P. aeruginosa homolog of IpaC. If, as our model proposes, residues near the IpaC (or 337 PopD) C-terminus loop into the pore lumen (Fig 3e-f and [16] ), then during docking, if the 338 needle tip complex partially enters the pore, it would be positioned to engage these 339 residues ( Fig S3) .
340
We and others postulated that effector secretion is activated by a signal(s) 
358
Our observation that S. flexneri docking to WT cells was blocked by intermolecular 359 crosslinking of IpaC molecules when crosslinking was induced during the initial contact 360 of bacteria with cells but not when crosslinking was induced at 10 minutes after initial 361 contact demonstrates that the processes required for docking are complete within 10 362 minutes. These data further support a model in which the initial conformation of the 363 translocon pore in the plasma membrane is not competent for docking and that, within 10 364 minutes, the pore converts to a docking-competent conformation. Our data show that this 365 conformational change is directly induced by the interaction of C-terminal residues of 366 membrane-embedded IpaC with intermediate filaments.
367
By mapping single cysteine substitutions of IpaC that are amenable to 368 intermolecular disulfide crosslinking, we build on our recent mapping of the topology of 369 natively-delivered IpaC [16] . Disulfide crosslinking requires an oxidizing environment, was 370 induced by the membrane-impermeant oxidant copper chloride (Fig 1) , and was blocked 371 by TCEP, a membrane-impermeant reductant ( Fig S1) . The successful crosslinking of a 372 subset of IpaC cysteine substitutions using these approaches indicated the presence of 373 the residue in an oxidizing environment accessible from the extracellular side of the 374 plasma membrane, which along with PEG5000-maleimide labeling (Fig 3) confirmed our 375 prior demonstration that the IpaC N-terminal region and the 19 residues closest to the 376 IpaC C-terminus are accessible from the extracellular environment and that the bulk of 20 377 the IpaC domain C-terminal to the alpha-helix is cytosolic (Figs 1 and 3, and [16] ). This 378 orientation of IpaC is similar for docking-competent and docking-incompetent pores ( Figs   379 1 and S2, and [16] ), which indicates that the interaction of IpaC with intermediate filaments 380 causes the repositioning of IpaC residues within the pore in a subtle manner that does 381 not alter the protein's overall orientation in the membrane. Since PEG5000-maleimide is 382 too large to cross the membrane or pass entirely through the pore [6], the observed 383 accessibility from the extracellular milieu of residues near the IpaC C-terminus to 384 PEG5000-maleimide is consistent with these residues looping back into the pore lumen 23 432 2, 4, and S1 were performed with copper phenanthroline, which is membrane-permeable.
433 The bacteria were centrifuged onto cells at 800 g for 10 minutes at 25C and incubated 434 at 37C in humidified air with 5% CO 2 for 10 min. IpaC delivered to cell membranes was 435 recovered as done previously [9] . Briefly, cells were washed with HBSS and lysed with 436 Triton X-100, and bacteria and cellular debris were removed by two successive 437 centrifugations at 21,000 g for 2 minutes each at 25C.
438
To test the effect of copper at later stages of infection, experiments were performed 439 as described as above except the infections were in HBSS containing 4% FBS and 1.2%
440 arabinose, and instead of adding copper at the same time as the bacteria, copper 441 phenanthroline was added immediately following the 10-minute centrifugation, to a final 442 concentration of 25 M.
443 Erythrocyte lysis assay
444
Pore formation in sheep erythrocyte membranes was monitored by assessing the 445 efficiency of erythrocyte lysis [5] . Briefly, 10 8 erythrocytes were washed with saline, and 446 co-cultured with S. flexneri at a multiplicity of 25 bacteria per erythrocyte in 30 mM Tris, 447 pH 7.5. After the bacteria were centrifuged onto the erythrocytes at 800 g for 10 minutes 448 at 25C, bacteria and erythrocytes were co-cultured for 30 minutes at 37C in humidified 449 air with 5% CO 2 . Bacteria and erythrocytes were then mixed by pipetting and again 450 centrifuged at 800 g for 10 minutes at 25C. As a control for lysis, a portion of uninfected 451 erythrocytes were treated with 0.02% SDS. The supernatants were collected, and the 452 abundance of hemoglobin released was determined spectrophotometrically by
